Quarterly Result24 Feb 2026, 04:09 pm
Nutraplus India Ltd Approves Quarterly Financial Results for Q4 2024 with Qualified Limited Review Report
AI Summary
Nutraplus India Limited, at its meeting held on March 6, 2025, has approved the Quarterly Financial Results with a Limited Review Report for the quarter ended December 31, 2024. The review report, issued by Raman S. Shah & Associates Chartered Accountants, contains a qualification due to the Company's non-compliance with listing requirements and delays in providing necessary financial data. The Company operates in the Active Pharmaceutical Ingredient (API) segment and the unaudited standalone financial results have been prepared in accordance with IND AS.
Key Highlights
- Nutraplus India Ltd approves Quarterly Financial Results for Q4 2024 with a qualified limited review report.
- The Company has not complied with listing requirements, leading to significant delays in the preparation and review of the quarterly financial results.
- The review report highlights the Company's failure to submit limited review reports and quarterly results within prescribed timelines.
- The Company operates in the Active Pharmaceutical Ingredient (API) segment.
- The unaudited standalone financial results have been prepared in accordance with IND AS.